GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » Short-Term Debt

PharmaCielo (TSXV:PCLO) Short-Term Debt : C$15.85 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is PharmaCielo Short-Term Debt?

PharmaCielo's Short-Term Debt for the quarter that ended in Dec. 2024 was C$15.85 Mil.

PharmaCielo's quarterly Short-Term Debt increased from Jun. 2024 (C$15.80 Mil) to Sep. 2024 (C$16.47 Mil) but then declined from Sep. 2024 (C$16.47 Mil) to Dec. 2024 (C$15.85 Mil).

PharmaCielo's annual Short-Term Debt increased from Dec. 2022 (C$0.55 Mil) to Dec. 2023 (C$15.71 Mil) and increased from Dec. 2023 (C$15.71 Mil) to Dec. 2024 (C$15.85 Mil).


PharmaCielo Short-Term Debt Historical Data

The historical data trend for PharmaCielo's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Short-Term Debt Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
Get a 7-Day Free Trial 0.09 0.08 0.55 15.71 15.85

PharmaCielo Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.71 15.77 15.80 16.47 15.85

PharmaCielo Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


PharmaCielo Short-Term Debt Related Terms

Thank you for viewing the detailed overview of PharmaCielo's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaCielo Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of its revenue in the form of the Sale of Cannabis derivative products in Colombia.
Executives
Ian D Atacan Director, Senior Officer
Marc Lustig Director
William Boris Petron Director
Henning Von Koss Director, Senior Officer
Anthony Wile 10% Security Holder

PharmaCielo Headlines